Krystal Biotech
company
A biotech investor has committed an additional $3 million to Krystal Biotech, boosting its capital as the company reports $389 million in revenue for 2025. The fresh funding is expected to support further development and growth initiatives.
Want to join the conversation?
Loading comments...
Comments
Want to join the conversation?
Loading comments...